As of Jun 29, 2018 Zosano Pharma Corporation (NASDAQ:ZSAN) Sellers Reduced Their Shorts By 43.02%

June 29, 2018 - By Eric Painter

It was registered a decrease on Zosano Pharma Corporation (NASDAQ:ZSAN)’s shorted shares with 43.02%. FINRA issued shorted shares of ZSAN’s total 924,200 shares. That’s 43.02% down from 1.62M shares. 2 days will cost ZSAN with 523,600 average volume to recover its previous position. 2.89% is Zosano Pharma Corporation float short.

Ticker’s shares touched $4.06 during the last trading session after 2.01% change.Currently Zosano Pharma Corporation is downtrending after 85.30% change in last June 29, 2017. ZSAN has 185,578 shares volume. ZSAN underperformed the S&P500 by 97.87%.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients.The firm is valued at $48.61 million. The Company’s lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine.Currently it has negative earnings.

For more Zosano Pharma Corporation (NASDAQ:ZSAN) news published recently go to: Streetinsider.com, Benzinga.com, Benzinga.com, Globenewswire.com or Benzinga.com. The titles are as follows: “Pre-Open Movers 06/28: (DRRX) (ZSAN) (CAVM) Higher; (ASNS) (PIR) (WBA) Lower (more…)” published on June 28, 2018, “48 Biggest Movers From Yesterday” on June 29, 2018, “20 Stocks Moving In Thursday’s Pre-Market Session” with a publish date: June 28, 2018, “Market Trends Toward New Normal in ANSYS, Pearson, Qualys, HB Fuller, Cabot Microelectronics, and Zosano …” and the last “60 Biggest Movers From Yesterday” with publication date: June 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.